dz

dz dz

sq 中文
电话 0731-85681666-8006

dz

1
current position：
Homepage
/
发展历程
/
Approved Drugs
/
On July 29, 2020, Gale Biotechnology (Hangzhou) Co., Ltd. was successfully approved as a Class 1 new drug for hepatitis C, Lavidavir Hydrochloride

On July 29, 2020, Gale Biotechnology (Hangzhou) Co., Ltd. was successfully approved as a Class 1 new drug for hepatitis C, Lavidavir Hydrochloride

  • Categories:Approved Drugs
  • Author:
  • Origin:
  • Time of issue:2020-07-29 17:12
  • Views:

On July 29, 2020, Gale Biotechnology (Hangzhou) Co., Ltd. was successfully approved as a Class 1 new drug for hepatitis C, Lavidavir Hydrochloride

  • Categories:Approved Drugs
  • Author:
  • Origin:
  • Time of issue:2020-07-29 17:12
  • Views:
Previous: July 13, 2020 Hunan Jiudian Pharmaceutical Co., Ltd. Pantoprazole sodium enteric-coated tablets is the second nationwide
Next: On October 26, 2020 Hunan Warner Pharmaceutical Co., Ltd. was the first nationally approved bismuth potassium citrate capsule
Previous: July 13, 2020 Hunan Jiudian Pharmaceutical Co., Ltd. Pantoprazole sodium enteric-coated tablets is the second nationwide
Next: On October 26, 2020 Hunan Warner Pharmaceutical Co., Ltd. was the first nationally approved bismuth potassium citrate capsule

Online

Online

TEL

0731-85681666-8006

WeChat

WeChat

TOP

搜索
Search
dz

Service Hotline：

0731-85681666-8006

Copyright © 2021 Changsha Duxact Biotech Co., Ltd.     湘ICP备 16006884号-1
www.300.cn      Changsha